• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

福利主义与超福利主义:经济评价方法的选择会影响经济评价研究推荐的采用决策吗?

Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?

作者信息

Buchanan James, Wordsworth Sarah

机构信息

Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7LF, UK,

出版信息

Pharmacoeconomics. 2015 Jun;33(6):571-9. doi: 10.1007/s40273-015-0261-3.

DOI:10.1007/s40273-015-0261-3
PMID:25680402
Abstract

A long-running debate surrounds the equivalence of the welfarist and extra-welfarist approaches to economic evaluation. There is a growing belief that the extra-welfarist approach may not necessarily provide all the information that decisionmakers require in certain contexts, e.g. evaluation of complex interventions. As the number of these interventions being evaluated increases, it is crucial that the most appropriate economic evaluation approach is used to enable decisionmakers to be confident in their adoption decisions. We conducted a literature review to evaluate the potential for the choice of economic evaluation approach to impact on the adoption decisions recommended by economic evaluation studies. We found that for every five studies applying both approaches, one shows limited or no concordance in economic evaluation results: the different approaches suggest conflicting adoption decisions, and there is no pattern to which approach provides the most convincing adoption evidence. Only one study in ten indicates which results will best inform adoption decisions. We conclude that the choice of approach can significantly impact on the adoption decisions recommended by economic evaluation studies, with conflicting results creating confusion over whether or not interventions provide good value for money. Health economists rarely provide sufficient guidance to decisionmakers to alleviate this confusion.

摘要

围绕福利主义和超福利主义经济评估方法的等效性存在长期争论。越来越多的人认为,超福利主义方法不一定能提供决策者在某些情况下所需的所有信息,例如对复杂干预措施的评估。随着这些被评估干预措施数量的增加,使用最合适的经济评估方法以使决策者对其采用决策有信心至关重要。我们进行了一项文献综述,以评估经济评估方法的选择对经济评估研究推荐的采用决策产生影响的可能性。我们发现,每五项同时应用这两种方法的研究中,就有一项在经济评估结果上显示出有限或无一致性:不同方法建议的采用决策相互冲突,且没有哪种方法能提供最有说服力的采用证据的模式。十分之一的研究中只有一项指出哪种结果最能为采用决策提供依据。我们得出结论,方法的选择会显著影响经济评估研究推荐的采用决策,相互冲突的结果会导致人们对干预措施是否物有所值产生困惑。卫生经济学家很少为决策者提供足够的指导来缓解这种困惑。

相似文献

1
Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?福利主义与超福利主义:经济评价方法的选择会影响经济评价研究推荐的采用决策吗?
Pharmacoeconomics. 2015 Jun;33(6):571-9. doi: 10.1007/s40273-015-0261-3.
2
Welfarism, extra-welfarism and capability: the spread of ideas in health economics.福利主义、超福利主义与能力:健康经济学中观念的传播
Soc Sci Med. 2008 Oct;67(7):1190-8. doi: 10.1016/j.socscimed.2008.06.027. Epub 2008 Jul 25.
3
Use of economic evaluation in local health care decision-making in England: a qualitative investigation.经济评估在英格兰地方医疗保健决策中的应用:一项定性研究。
Health Policy. 2009 Mar;89(3):261-70. doi: 10.1016/j.healthpol.2008.06.004. Epub 2008 Jul 25.
4
Concepts of 'personalization' in personalized medicine: implications for economic evaluation.个性化医疗中的“个性化”概念:对经济评估的影响
Pharmacoeconomics. 2015 Jan;33(1):49-59. doi: 10.1007/s40273-014-0211-5.
5
Welfarism and extra-welfarism: a critical overview.福利主义与超福利主义:批判性综述
Cad Saude Publica. 2017 Aug 21;33(8):e00014317. doi: 10.1590/0102-311X00014317.
6
Maximisation in extra-welfarism: A critique of the current position in health economics.超福利主义中的最大化:对健康经济学当前立场的批判
Soc Sci Med. 2009 Sep;69(5):786-92. doi: 10.1016/j.socscimed.2009.06.026. Epub 2009 Jul 14.
7
The complex interface between economy and healthcare: An introductory overview for clinicians.经济与医疗保健之间的复杂界面:给临床医生的初步概述
Eur J Intern Med. 2016 Dec;36:1-6. doi: 10.1016/j.ejim.2016.07.030. Epub 2016 Aug 28.
8
Generalisability in economic evaluation studies in healthcare: a review and case studies.医疗保健经济评估研究中的可推广性:综述与案例研究
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Introduction to health economics and decision-making: Is economics relevant for the frontline clinician?健康经济学与决策导论:经济学对于一线临床医生而言是否重要?
Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):831-44. doi: 10.1016/j.bpg.2013.08.016. Epub 2013 Sep 26.

引用本文的文献

1
Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation.超越诊断:使用条件价值评估法评估全基因组测序在罕见病诊断中的价值
Appl Health Econ Health Policy. 2025 May;23(3):425-439. doi: 10.1007/s40258-025-00948-x. Epub 2025 Mar 14.
2
Cost-Benefit and Cost-Utility Analyses to Demonstrate the Potential Value-for-Money of Supermarket Shelf Tags Promoting Healthier Packaged Products in Australia.成本效益和成本效用分析表明,在澳大利亚,超市货架标签促进更健康包装产品具有潜在的性价比。
Nutrients. 2022 May 3;14(9):1919. doi: 10.3390/nu14091919.
3
Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

本文引用的文献

1
Economic evaluations in bipolar disorder: a systematic review and critical appraisal.双相情感障碍的经济学评估:系统评价与批判性评估
Bipolar Disord. 2014 Sep;16(6):557-82. doi: 10.1111/bdi.12213. Epub 2014 Jun 11.
2
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.健康经济评估报告标准(CHEERS)声明。
Pharmacoeconomics. 2013 May;31(5):361-7. doi: 10.1007/s40273-013-0032-y.
3
Should we invest in environmental interventions to encourage physical activity in England? An economic appraisal.
在质量调整生命年背景下对“健康之外的益处”进行概念化:一项批判性解释性综述
Pharmacoeconomics. 2021 Dec;39(12):1383-1395. doi: 10.1007/s40273-021-01074-x. Epub 2021 Aug 23.
4
Aspects and Challenges of Resource Use Measurement in Health Economics: Towards a Comprehensive Measurement Framework.卫生经济学中资源利用测量的方面和挑战:迈向全面的测量框架。
Pharmacoeconomics. 2021 Sep;39(9):983-993. doi: 10.1007/s40273-021-01048-z. Epub 2021 Jun 25.
5
A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders.比较传统和大规模平行测序诊断疑似遗传疾病路径的卫生经济学研究综述。
Pharmacoeconomics. 2020 Feb;38(2):143-158. doi: 10.1007/s40273-019-00856-8.
6
Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?将定量患者偏好数据纳入医疗保健决策过程:卫生技术评估是否落后了?
Patient. 2018 Jun;11(3):249-252. doi: 10.1007/s40271-018-0305-9.
7
Cost-effectiveness analyses of genetic and genomic diagnostic tests.遗传和基因组诊断测试的成本效益分析。
Nat Rev Genet. 2018 Apr;19(4):235-246. doi: 10.1038/nrg.2017.108. Epub 2018 Jan 22.
8
Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review.特应性皮炎预防与治疗的经济学证据:一项系统评价方案
Syst Rev. 2016 May 27;5:90. doi: 10.1186/s13643-016-0262-0.
9
Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment.患者对慢性淋巴细胞白血病基因诊断检测的偏好:一项离散选择实验。
Patient. 2016 Dec;9(6):525-536. doi: 10.1007/s40271-016-0172-1.
我们是否应该投资环境干预措施以鼓励英格兰的身体活动?一项经济评估。
Eur J Public Health. 2012 Dec;22(6):869-73. doi: 10.1093/eurpub/ckr151. Epub 2012 Feb 24.
4
Smoke alarm giveaway and installation programs: an economic evaluation.烟雾报警器赠送和安装计划:经济评估。
Am J Prev Med. 2012 Oct;43(4):385-91. doi: 10.1016/j.amepre.2012.06.021.
5
The economic evaluation of a participatory ergonomics programme to prevent low back and neck pain.一项预防腰背痛和颈痛的参与式工效学计划的经济评估。
Work. 2012;41 Suppl 1:2315-20. doi: 10.3233/WOR-2012-0458-2315.
6
Valuing the economic benefits of complex interventions: when maximising health is not sufficient.重视复杂干预措施的经济效益:当最大化健康收益不再足够时。
Health Econ. 2013 Mar;22(3):258-71. doi: 10.1002/hec.2795. Epub 2012 Feb 6.
7
The costs and benefits of deep brain stimulation surgery for patients with dystonia: an initial exploration.深部脑刺激手术治疗肌张力障碍患者的成本效益:初步探讨。
Neuromodulation. 2005 Jul;8(3):155-61. doi: 10.1111/j.1525-1403.2005.05233.x.
8
What needs to be done in contingent valuation: have Smith and Sach missed the boat?
Health Econ Policy Law. 2010 Jan;5(Pt 1):113-21. doi: 10.1017/s174413310999003x.
9
The potential to forgo social welfare gains through overrelianceon cost effectiveness/cost utility analyses in the evidence base for public health.在公共卫生证据基础中过度依赖成本效益/成本效用分析,可能会放弃社会福利收益。
J Environ Public Health. 2009;2009:107927. doi: 10.1155/2009/107927. Epub 2009 Dec 2.
10
Contingent valuation: what needs to be done?条件价值评估:需要做什么?
Health Econ Policy Law. 2010 Jan;5(Pt 1):91-111. doi: 10.1017/S1744133109990016.